Pink1 and parkin demonstrate multifaceted roles when co-expressed with Foxo - Advances in Parkinson's Disease

APD > Vol.2 No.1, February 2013

Pink1 and parkin demonstrate multifaceted roles when co-expressed with Foxo ()

HTML XML

Download as PDF (Size: 1387KB) PP. 5-10

DOI: 10.4236/apd.2013.21002 5,090 Downloads 9,032 Views Citations

Author(s)

Amy M. Todd, Brian E. Staveley

Affiliation(s)

Department of Biology, Memorial University of Newfoundland, St. John’s, Canada.

ABSTRACT

Pink1 has been linked to both autosomal recessive and sporadic forms of Parkinson disease. The Pink1 protein is thought to be involved in mitochondrial protection by interacting with parkin to prevent oxidative damage, maintain mitochondrial integrity and regulate mitophagy. Pink1 and parkin have been linked to components of the insulin receptor (INR) pathway, including PTEN, Akt and Foxo, but their effects in the INR pathway have been largely overlooked. To further investigate the roles of Pink1/parkin, we have performed co-expression studies to determine the effects Pink1 and parkin on the Foxo-induced phenotype of developmental defects in the Drosophila eye. We examined directed expression of Pink1, parkin, Pink1 or parkin mutants, and Pink1 or parkin interfering RNAs (RNAi) with the overexpression of Foxo in the developing eye of Drosophila. Our findings show that reduction of Pink1 suppresses the effects of Foxo overexpression, where co-overexpression with Pink1 or parkin increases the severity of the phenotype. This suggests that Pink1 and parkin are able to increase the pro-apoptotic effects of Foxo. Contrary to the view that Pink1 and parkin act exclusively as protective proteins in the cell, it is likely that the Pink1/parkin pathway is involved in aspects of cell fate decisions other than degrading toxic proteins and maintaining mitochondrial integrity.

KEYWORDS

Pink1; Parkin; Foxo; Drosophila

Share and Cite:

M. Todd, A. and E. Staveley, B. (2013) Pink1 and parkin demonstrate multifaceted roles when co-expressed with Foxo. Advances in Parkinson's Disease, 2, 5-10. doi: 10.4236/apd.2013.21002.

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies